Clinical Trial Update: Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial update describes recruitment for blinatumomab intensification in patients with MRD-negative acute B-lymphoblastic leukemia before undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia B-precursor

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Lymphoblastic Leukemia, B-precursor | NA | Status: RECRUITING